Eton Pharmaceutcials
ETON
14 hedge funds and large institutions have $18.9M invested in Eton Pharmaceutcials in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
31% more capital invested
Capital invested by funds: $14.4M → $18.9M (+$4.49M)
1.9% more ownership
Funds ownership: 12.82% → 14.73% (+1.9%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.88M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$390K |
| 3 |
PCM
Prelude Capital Management
New York
|
+$334K |
| 4 |
BlackRock
New York
|
+$228K |
| 5 |
AIC
AWM Investment Company
New York
|
+$206K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$1.03M |
| 2 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$228K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$13K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.94K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.55K |
ETON Hedge Fund Activity: Q4 2019 in Review
14 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q4 2019, worth a combined $18.9M — up 31% from $14.4M a quarter earlier.
Fund positioning in ETON was balanced in Q4 2019: 3 funds opened new positions, 3 closed out, 7 added to existing stakes and 2 trimmed.
The largest buyer was Opaleye Management, adding an estimated $1.88M. The largest seller was Diametric Capital, exiting entirely with an estimated $1.03M sold.
- 14 institutional investors held Eton Pharmaceutcials (ETON) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $18.9M of Eton Pharmaceutcials stock for Q4 2019, up 31% quarter-over-quarter.
- 3 funds opened new Eton Pharmaceutcials positions in Q4 2019 and 3 closed out, a net change of 0 holders.
- The largest Eton Pharmaceutcials buyer in Q4 2019 was Opaleye Management, an estimated $1.88M added.
- The largest Eton Pharmaceutcials seller in Q4 2019 was Diametric Capital, an estimated $1.03M sold.
Based on aggregated 13F filings for Q4 2019.